UCART

Clinical trials for UCART explained in plain language.

Never miss a new study

Get alerted when new UCART trials appear

Sign up with your email to follow new studies for UCART, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take on tough blood disorder

Disease control Recruiting now

This early-stage study tests a new treatment for people with a severe type of autoimmune hemolytic anemia (AIHA) that hasn't improved after at least three prior therapies. The treatment uses specially engineered immune cells (CAR-T cells) from a healthy donor to target and destro…

Matched conditions: UCART

Phase: EARLY_PHASE1 • Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

UCART

Get alerted when new UCART trials appear

Engineered immune cells take on tough blood disorder